These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3002339)

  • 1. Structural features involved in the biological activity of insulin and the insulin-like growth factors: A27 insulin/BIGF-I.
    Joshi S; Ogawa H; Burke GT; Tseng LY; Rechler MM; Katsoyannis PG
    Biochem Biophys Res Commun; 1985 Dec; 133(2):423-9. PubMed ID: 3002339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic activity and receptor reactivity of hybrid molecules containing portions of the insulin-like growth factor I (IGF-I), IGF-II, and insulin molecules.
    De Vroede MA; Rechler MM; Nissley SP; Ogawa H; Joshi S; Burke GT; Katsoyannis PG
    Diabetes; 1986 Mar; 35(3):355-61. PubMed ID: 3005095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid molecules containing the A-domain of insulin-like growth factor-I and the B-chain of insulin have increased mitogenic activity relative to insulin.
    Tseng LY; Schwartz GP; Sheikh M; Chen ZZ; Joshi S; Wang JF; Nissley SP; Burke GT; Katsoyannis PG; Rechler MM
    Biochem Biophys Res Commun; 1987 Dec; 149(2):672-9. PubMed ID: 2447882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of growth-promoting activity reside in the A-domain of insulin-like growth factor I.
    Chen ZZ; Schwartz GP; Zong L; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1988 Aug; 27(16):6105-11. PubMed ID: 3056519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells.
    Conti FG; Striker LJ; Lesniak MA; MacKay K; Roth J; Striker GE
    Endocrinology; 1988 Jun; 122(6):2788-95. PubMed ID: 2967178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells.
    Pepe MG; Ginzton NH; Lee PD; Hintz RL; Greenberg PL
    J Cell Physiol; 1987 Nov; 133(2):219-27. PubMed ID: 2960684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of acute effects of insulin-like growth factors I and II in human fat cells.
    Bolinder J; Lindblad A; Engfeldt P; Arner P
    J Clin Endocrinol Metab; 1987 Oct; 65(4):732-7. PubMed ID: 2958492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I/somatomedin-C (IGF-I/SM-C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts.
    Conover CA; Dollar LA; Hintz RL; Rosenfeld RG
    J Cell Physiol; 1983 Aug; 116(2):191-7. PubMed ID: 6306016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid molecules containing the B-domain of insulin-like growth factor I are recognized by carrier proteins of the growth factor.
    De Vroede MA; Rechler MM; Nissley SP; Joshi S; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1985 May; 82(9):3010-4. PubMed ID: 2581261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.
    Gauguin L; Klaproth B; Sajid W; Andersen AS; McNeil KA; Forbes BE; De Meyts P
    J Biol Chem; 2008 Feb; 283(5):2604-13. PubMed ID: 18048361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of an insulin-like compound consisting of the A chain of insulin and a B chain corresponding to the B domain of human insulin-like growth factor I.
    Joshi S; Burke GT; Katsoyannis PG
    Biochemistry; 1985 Jul; 24(15):4208-14. PubMed ID: 3902081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue.
    Kern PA; Svoboda ME; Eckel RH; Van Wyk JJ
    Diabetes; 1989 Jun; 38(6):710-7. PubMed ID: 2542108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin and insulin-like growth factor (IGF) responsiveness by IGFs in rat hepatoma cells.
    Heaton JH; Krett NL; Gelehrter TD
    Endocrinology; 1986 Jun; 118(6):2555-60. PubMed ID: 2870917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport.
    Sinha MK; Buchanan C; Leggett N; Martin L; Khazanie PG; Dimarchi R; Pories WJ; Caro JF
    Diabetes; 1989 Oct; 38(10):1217-25. PubMed ID: 2551760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ autoradiography and ligand-dependent tyrosine kinase activity reveal insulin receptors and insulin-like growth factor I receptors in prepancreatic chicken embryos.
    Girbau M; Bassas L; Alemany J; de Pablo F
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5868-72. PubMed ID: 2548191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
    Myal Y; Shiu RP; Bhaumick B; Bala M
    Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin-like growth factors on chick embryo hepatocytes.
    Widmer U; Schmid C; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):237-44. PubMed ID: 2578720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor II binding and action in human fetal fibroblasts.
    Conover CA; Rosenfeld RG; Hintz RL
    J Cell Physiol; 1987 Dec; 133(3):560-6. PubMed ID: 2961773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin.
    Rechler MM; Nissley SP; King GL; Moses AC; Van Obberghen-Schilling EE; Romanus JA; Knight AB; Short PA; White RM
    J Supramol Struct Cell Biochem; 1981; 15(3):253-86. PubMed ID: 6267316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factors decrease oxygen-regulated erythropoietin production by human hepatoma cells (Hep G2).
    Scholz H; Baier W; Ratcliffe P; Eckardt K; Zapf J; Kurtz A; Bauer C
    Am J Physiol; 1992 Aug; 263(2 Pt 1):C474-9. PubMed ID: 1325119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.